Considerations for randomizing 1 eye or 2 eyes.
National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, England2Cochrane Eyes and Vision Group, London School of Hygiene and Tropical Medicine, London, E.
Catey
C
Bunce
National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, England2Cochrane Eyes and Vision Group, London School of Hygiene and Tropical Medicine, London, E.
Richard
R
Wormald
D003627:Data Interpretation, Statistical; D005128:Eye Diseases / Q000188:drug therapy*; D006801:Humans; D009883:Ophthalmic Solutions / Q000008:administration & dosage*; D009885:Ophthalmology / Q000706:statistics & numerical data*; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data*
D009883:Ophthalmic Solutions; D004364:Pharmaceutical Preparations